How QIAGEN’s FDA-cleared QIAstat-Dx test supports the Cyclospora outbreak response
QIAGEN highlights its FDA-cleared QIAstat-Dx panel as U.S. Cyclospora cases rise, while research tools support outbreak tracing.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
How QIAGEN’s QIAstat-Dx Rise GI panel clearance could reshape multiplex pathogen testing in clinical labs
QIAGEN wins FDA clearance for GI panels on QIAstat-Dx Rise. Discover what this means for syndromic testing platforms and molecular diagnostics adoption.